Amneal Pharmaceuticals Quote - AMRX

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

8.73

Bid

8.65

Ask

9.00

Volume

0.00 Day's Range 0.00

5.01 52 Week Range 9.475

Market Cap

2.705B

Previous Close

8.73

Open

Last Trade

8.65

Last Trade Time

07:52:10

Financial Volume

VWAP

Average Volume (3m)

1,160,960

Shares Outstanding

309,844,430

Dividend Yield

PE Ratio

-21.65

Earnings Per Share (EPS)

-0.27

Revenue

2.41B

Net Profit

-83.99M

Amneal Pharmaceuticals Inc is a generic pharmaceutical manufacturer. The company's reportable segments are Generic Products, Specialty products, and AvKARE. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inha... Amneal Pharmaceuticals Inc is a generic pharmaceutical manufacturer. The company's reportable segments are Generic Products, Specialty products, and AvKARE. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals, and the Specialty segment is engaged in the development, promotion, sale and distribution of proprietary branded pharmaceutical products. The AvKARE segment provides pharmaceuticals, medical and surgical products, and services primarily to governmental agencies. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.amneal.com

Headquarters

Wilmington, Delaware, USA

Founded

Amneal Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker AMRX. The last closing price for Amneal Pharmaceuticals was US$8.73. Over the last year, Amneal Pharmaceuticals shares have traded in a share price range of US$ 5.01 to US$ 9.475.

Amneal Pharmaceuticals currently has 309,844,430 shares outstanding. The market capitalization of Amneal Pharmaceuticals is US$2.70 billion. Amneal Pharmaceuticals has a price to earnings ratio (PE ratio) of -21.65.

Amneal to Report Fourth Quarter and Full Year 2024 Results on February 28, 2025

Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) (“Amneal” or the “Company”), a global biopharmaceutical company, today announced that the Company will release its fourth quarter and full year 2024...

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Amneal Receives U.S. FDA Approval for Memantine/Donepezil Extended-Release Capsules and Everolimus Tablets for Oral Suspension, and Tentative U.S. FDA Approval for Rifaximin

Approval of three important therapies for dementia, oncology and gastrointestinal disease Granted 180-day exclusivity for memantine/donepezil extended-release capsules Tentative approval of...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.12	1.393728223	8.61	8.88	8.375	824925	8.69638063	CS
4	0.7596	9.53026196929	7.9704	8.88	7.625	1111307	8.18933059	CS
12	0.35	4.17661097852	8.38	9.475	7.52	1160960	8.32389643	CS
26	1.29	17.3387096774	7.44	9.475	6.5	1170538	8.2537004	CS
52	3.09	54.7872340426	5.64	9.475	5.01	1339392	7.09522356	CS
156	2.85	48.4693877551	5.88	9.475	5.01	1344058	6.97943481	CS
260	2.85	48.4693877551	5.88	9.475	5.01	1344058	6.97943481	CS

AMRX - Frequently Asked Questions (FAQ)

What is the current Amneal Pharmaceuticals share price?

The current share price of Amneal Pharmaceuticals is US$ 8.73

How many Amneal Pharmaceuticals shares are in issue?

Amneal Pharmaceuticals has 309,844,430 shares in issue

What is the market cap of Amneal Pharmaceuticals?

The market capitalisation of Amneal Pharmaceuticals is USD 2.7B

What is the 1 year trading range for Amneal Pharmaceuticals share price?

Amneal Pharmaceuticals has traded in the range of US$ 5.01 to US$ 9.475 during the past year

What is the PE ratio of Amneal Pharmaceuticals?

The price to earnings ratio of Amneal Pharmaceuticals is -21.65

What is the cash to sales ratio of Amneal Pharmaceuticals?

The cash to sales ratio of Amneal Pharmaceuticals is 0.75

What is the reporting currency for Amneal Pharmaceuticals?

Amneal Pharmaceuticals reports financial results in USD

What is the latest annual turnover for Amneal Pharmaceuticals?

The latest annual turnover of Amneal Pharmaceuticals is USD 2.41B

What is the latest annual profit for Amneal Pharmaceuticals?

The latest annual profit of Amneal Pharmaceuticals is USD -83.99M

What is the registered address of Amneal Pharmaceuticals?

The registered address for Amneal Pharmaceuticals is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801

What is the Amneal Pharmaceuticals website address?

The website address for Amneal Pharmaceuticals is www.amneal.com

Which industry sector does Amneal Pharmaceuticals operate in?

Amneal Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
AALAmerican Airlines Group Inc	US$ 17.15 (0.00%)	82.95k
AAGRAfrican Agriculture Holdings Inc	US$ 0.1326 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	US$ 73.8983 (0.00%)	0
AADIAadi Bioscience Inc	US$ 2.83 (0.00%)	16
AACGATA Creativity Global	US$ 0.84 (0.00%)	65
RLMDRelmada Therapeutics Inc	US$ 0.3401 (-6.67%)	5.12k
AAGRAfrican Agriculture Holdings Inc	US$ 0.1326 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	US$ 73.8983 (0.00%)	0
AADIAadi Bioscience Inc	US$ 2.83 (0.00%)	16
AACGATA Creativity Global	US$ 0.84 (0.00%)	65
SLXNSilexion Therapeutics Corporation	US$ 1.35 (0.00%)	69.68M
OCEAOcean Biomedical Inc	US$ 0.33 (0.00%)	47.89M
EVTVEnvirotech Vehicles Inc	US$ 0.569 (0.00%)	33.59M
SXTP60 Degrees Pharmaceuticals Inc	US$ 0.7708 (0.00%)	32.67M
LGCLLucas GC Ltd	US$ 0.572 (0.00%)	24.35M